8 November 2017

Kenya: City Billionaire Chris Kirubi in U.S. for Specialised Treatment

Chris Kirubi, business tycoon and director of NSE-listed investment company Centum, has flown to the US for specialised treatment after receiving medication in a top local hospital for about two weeks.

Centum chief executive James Mworia confirmed the sickness in an internal memo sent to staff late last week.

Mr Kirubi, who is in his seventies, has wide-ranging business interests in publicly listed as well as private companies.

He is the single-largest shareholder of the Nairobi Securities Exchange traded Centum Investments with a 28.64 per cent stake.

DISCLOSE SICKNESS

"Dr Kirubi... travelled to the United States for further investigations on Monday," said Mr Mworia in the memo that did not, however, disclose the sickness.

The Centum boss, however, sought to dispel speculation that Mr Kirubi is in a critical condition, while also discounting reports that the business magnate had been treated in an Intensive Care Unit (ICU).

"Instead, Dr Kirubi, whom I spent time with on Monday and saw off at the airport, and have spoken to on multiple occasions since, remains in good spirits and actively engaged on business matters in his usual endearing fashion," added Mr Mworia.

When reached for comment, Mr Mworia told the Business Daily that he did not wish to make any public statement on the matter that he described as a private affair.

He, however, said that the businessman is doing well.

Mr Kirubi, one of Kenya's most prolific businessmen, holds leadership positions in at least 10 companies and organisations, including a non-executive directorship at Centum Investments.

DIVERSE BUSINESS INTERESTS

His business interests are diverse, ranging from broadcasting, Capital Media Group, to manufacturing, Haco Tiger Brands.

An alumnus of the Harvard Business School, he previously served as chairman of Centum between 1998 and 2003. He chairs the board of Haco Tiger Brands where he has a 49 per cent stake.

Mr Kirubi is currently negotiating a deal in which he is set to become the sole shareholder of the company after buying back 51 per cent from the South African company Tiger Brands.

He also heads the board of Nairobi Bottlers, a local franchisee of Coca-Cola, which accounts for 47 per cent of all beverage sales in Kenya.

In June it became public that Mr Kirubi owns 45 per cent of agrochemical firm Bayer East Africa, a firm that is set for a merger with the local subsidiary of Monsanto as part of a larger global transaction valued at Sh6.2 trillion.

BUSINESS EMPIRE

He has previously said that that property is the foundation of his business empire and International House in Nairobi's Central Business District is one of his most iconic investments.

Through Centum Investments, he has an interest in some of East Africa's most ambitious property developments including Two Rivers in Gigiri and the Pearl Marina Project in Uganda.

Mr Kirubi steers the efforts to market Kenya to investors and tourists as chairman of the Brand Kenya Initiative.

Kenya

Supreme Court Upholds Kenyatta's Re-Election

The Supreme Court has in a unanimous decision, dismissed the petitions challenging the validity of the October 26… Read more »

Copyright © 2017 Nairobi News. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica publishes around 900 reports a day from more than 140 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.